Citation Impact
Citing Papers
Efficacy of Exercise Interventions in Modulating Cancer-Related Fatigue among Adult Cancer Survivors: A Meta-Analysis
2011
Novel Immunotherapy for Malignant Melanoma with a Monoclonal Antibody That Blocks CEACAM1 Homophilic Interactions
2012
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change
2009
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
2007
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
2008
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
A telephone‐delivered lifestyle intervention for colorectal cancer survivors ‘CanChange’: a pilot study
2009
Smarter drugs emerging in pancreatic cancer therapy
2014
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
Pathogenetic Mechanisms of Septic Shock
1993 Standout
Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon‐26 adenocarcinoma
2004
Correlates of physical activity: why are some people physically active and others not?
2012 Standout
Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial
2008
How much can current interventions reduce colorectal cancer mortality in the U.S.?
2006
Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
2007
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients
1997
Cancer statistics, 2013
2013 Standout
Management of muscle wasting in cancer-associated cachexia
2001
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
The pharmacology of dichloroacetate
1989
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Targeted treatments in colorectal cancer: state of the art and future perspectives
2010
Metabolism and action of amino acid analog anti-cancer agents
1990
Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue.
2007
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Update on anorexia and cachexia
2002
Is there a role for TPN in terminally ill patients with bowel obstruction?
2004
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
2012
Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor‐bearing mice
2004
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Associations Between Exercise, Quality of Life, and Fatigue in Colorectal Cancer Survivors
2008
Evaluation of a 12-week home-based walking intervention for breast cancer survivors
2006
Colorectal cancer
2013 Standout
Effects of a Walking Intervention on Fatigue-Related Experiences of Hospitalized Acute Myelogenous Leukemia Patients Undergoing Chemotherapy: A Randomized Controlled Trial
2008
Depression as a predictor of disease progression and mortality in cancer patients
2009
Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats
1999
Pancreatic Adenocarcinoma
2014 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Colorectal cancer
2019 Standout
Cancer-associated cachexia
2018 Standout
Global cancer statistics
2011 Standout
Understanding and Managing Cancer Cachexia
2003
Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer
2007
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices
2006
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Sarcopenia
2019 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Physical activity and function in older, long-term colorectal cancer survivors
2009
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Subjective wellbeing, health, and ageing
2014 StandoutNobel
Ventilator-Induced Lung Injury
2013 Standout
Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention
2009
Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery
1994
An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis
2010
Pancreatic Cancer
2010 Standout
Strategies for optimizing combinations of molecularly targeted anticancer agents
2006
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
1998
Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia
1999
Exercise Interventions for Cancer Survivors: A Meta-Analysis of Quality of Life Outcomes
2010
Physical Activity Motivation and Cancer Survivorship
2010
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Cancer Statistics, 2010
2010 Standout
Pancreatic cancer
2011 Standout
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
2005
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Alveolar Hypoxia Increases Gene Expression of Extracellular Matrix Proteins and Platelet-derived Growth Factor-B in Lung Parenchyma
1998
Ventilator-induced Lung Injury
1998 Standout
Cancer-related fatigue: A systematic and meta-analytic review of non-pharmacological therapies for cancer patients.
2008
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803
2006
Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803
2008
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Social isolation, loneliness, and all-cause mortality in older men and women
2013 Standout
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
2009
EpCAM and the biology of hepatic stem/progenitor cells
2014
Exercise interventions on health-related quality of life for cancer survivors
2012
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Regulation of Protein Catabolism by Muscle-Specific and Cytokine-Inducible Ubiquitin Ligase E3α-II during Cancer Cachexia
2004
Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase III
2008
Multivitamin Use Is Not Associated With Cancer Recurrence or Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803
2010
Mechanotransduction Across the Cell Surface and Through the Cytoskeleton
1993 StandoutScience
Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome
2004 Standout
The Pancreas Cancer Microenvironment
2012
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
2009
Regulation of protein turnover in skeletal and cardiac muscle
1991
Cancer statistics, 2016
2016 Standout
Targeting Signal Transduction Pathways in Colorectal Cancer—More Than Skin Deep
2005
Cancer statistics, 2015
2015 Standout
Clinical predictors of survival in advanced cancer.
2005
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
2005
Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study
2005
Energetics in Colorectal and Prostate Cancer
2010
Oxygen Delivery and Utilization in Sepsis
1989
Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative Care
2005
Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001
2008
Missense mutations of the BRAF gene in human lung adenocarcinoma.
2002
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Impact of a Mixed Strength and Endurance Exercise Intervention on Insulin Levels in Breast Cancer Survivors
2008
Global cancer statistics, 2012
2015 Standout
Direct stimulation of adenylate cyclase by mechanical forces in S49 mouse lymphoma cells during hyposmotic swelling.
1990
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases
2006
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
2012
Determinants of initiation and maintenance of physical activity among older adults: a literature review
2009
Works of Anthony Fields being referenced
A randomized trial of exercise and quality of life in colorectal cancer survivors
2003
Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada clinical trials group study
1987
Clinical Survival Predictors in Patients With Advanced Cancer
2000
Predictors of adherence and contamination in a randomized trial of exercise in colorectal cancer survivors
2004
Lactic Acidosis — Emphasis on the Carbon Precursors Buffering of the Acid Load
1985
Accelerated loss of lean body mass in fasting rats due to activation of pyruvate dehydrogenase by dichloroacetate
1987
Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
2007
Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
2009
Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2003
Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: a National Cancer Institute of Canada clinical trials group study.
2002
Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)
2004
Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats
1989
A Longitudinal Study of Exercise Barriers in Colorectal Cancer Survivors Participating in a Randomized Controlled Trial
2005
Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)
2004
Systemic Infusion Versus Bolus Chemotherapy with 5-Fluorouracil in Measurable Metastatic Colorectal Cancer
1992